Clinical trials in Contamine-Sur-Arve – page 2

In Contamine-Sur-Arve, several trials focus on neoplasms, especially lung cancer, breast cancer, ovarian cancer, and colon cancer. These studies are aimed at improving survival, reducing recurrence, and helping doctors choose more effective treatment strategies.

• Testing new approaches for non-small cell lung cancer and small cell lung cancer
• Studying treatment options for HER2-positive, HR-positive, and high-risk breast cancer
• Evaluating better care for ovarian cancer and colon cancer
• Assessing therapies that may improve progression-free survival and disease-free survival

This area reflects a strong interest in both advanced treatment and more precise cancer decision-making.

Research in respiratory tract diseases centers on lung cancer and acute pneumonia, with trials exploring better ways to control disease and improve outcomes for older and high-risk patients.

• Evaluating treatment strategies for advanced lung cancer
• Studying adjuvant care after surgery for resected non-small cell lung cancer
• Testing supportive treatment for acute pneumonia in older adults

The work in this field aims to refine both cancer therapy and infection management in respiratory care.

Trials in bacterial infections are examining treatment options for staphylococcal prosthetic joint infection, with the goal of improving infection control while preserving joint function.

• Studying oral antibiotic options for prosthetic joint infection
• Supporting better management of staphylococcal infections
• Looking at treatment effectiveness in debridement and implant retention care

This research focuses on practical infection treatment choices that may help patients avoid more invasive care.

Studies in digestive system diseases are centered on colon cancer and upper rectal cancer, with a clear focus on improving relapse prevention after surgery.

• Evaluating adjuvant treatment for colon adenocarcinoma
• Studying relapse-free survival after resection of stage III colon cancer
• Using new markers to guide therapy for colon cancer

These trials aim to support more personalized follow-up care after curative surgery.

In the field of nervous system diseases, trials are focused on multiple sclerosis, comparing therapies designed to lower relapse frequency and improve long-term disease control.

• Assessing treatment effectiveness in relapsing multiple sclerosis
• Comparing approaches that may reduce confirmed relapses
• Exploring better long-term control of chronic neurological disease

The goal is to identify options that provide steadier disease management for patients over time.

Research in diagnostic and therapeutic techniques includes studies using blood-based markers and other tools to guide treatment decisions in cancer and inflammatory disease.

• Using circulating tumor DNA to guide adjuvant care in colon cancer
• Exploring molecular response to help select therapy in metastatic breast cancer
• Investigating precision approaches in lung cancer and ovarian cancer

These studies highlight a broader move toward more individualized diagnosis and treatment planning.

Trials also address serious autoimmune conditions such as ANCA vasculitis and end-stage renal disease, with a focus on balancing disease control and treatment burden.

• Evaluating whether treatment can be safely reduced in ANCA vasculitis
• Studying outcomes in patients with end-stage renal disease
• Looking at long-term safety and survival-related outcomes

This work seeks to support safer, more sustainable care for patients with complex chronic illness.

The local research portfolio in Contamine-Sur-Arve also includes studies in broader therapeutic areas, such as treatment optimization for older adults and evaluation of supportive care strategies.

• Improving care for older patients with breast cancer and lung cancer
• Assessing treatment strategies for high-risk patients across several diseases
• Exploring ways to improve survival and reduce relapse in difficult-to-treat conditions

Together, these trials show a diverse clinical research environment with a strong emphasis on practical patient benefit.